MHC class II molecules enhance Toll-like receptor mediated innate immune responses by Frei, R et al.
MHC Class II Molecules Enhance Toll-Like Receptor
Mediated Innate Immune Responses
Remo Frei1*, Johanna Steinle1, Thomas Birchler2, Susanne Loeliger1, Caroline Roduit1, Dirk Steinhoff1,
Reinhart Seibl1, Katja Bu¨chner1, Reinhard Seger1, Walter Reith3, Roger P. Lauener1*
1Division of Immunology/Allergology, University of Zurich, Children’s Hospital, Zurich, Switzerland, 2 Section of Clinical Immunology, University Hospital Zurich, Zurich,
Switzerland, 3Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland
Abstract
Background: Major histocompatibility complex (MHC) class II molecules play crucial roles in immune activation by
presenting foreign peptides to antigen-specific T helper cells and thereby inducing adaptive immune responses. Although
adaptive immunity is a highly effective defense system, it takes several days to become fully operational and needs to be
triggered by danger-signals generated during the preceding innate immune response. Here we show that MHC class II
molecules synergize with Toll-like receptor (TLR) 2 and TLR4 in inducing an innate immune response.
Methodology/Principal Findings: We found that co-expression of MHC class II molecules and TLR2 or TLR4 in human
embryonic kidney (HEK) cells 293 leads to enhanced production of the anti-microbial peptide human-b-defensin (hBD) 2
after treatment with TLR2 stimulus bacterial lipoprotein (BLP) or TLR4 ligand lipopolysaccharide (LPS), respectively.
Furthermore, we found that peritoneal macrophages of MHC class II knock-out mice show a decreased responsiveness to
TLR2 and TLR4 stimuli compared to macrophages of wild-type mice. Finally, we show that MHC class II molecules are
physically and functionally associated with TLR2 in lipid raft domains of the cell membrane.
Conclusions/Significance: These results demonstrate that MHC class II molecules are, in addition to their central role in
adaptive immunity, also implicated in generating optimal innate immune responses.
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Introduction
Innate immunity mediates the first immune response to
evolutionary conserved foreign patterns upon their recognition
by pattern recognition receptors. TLR are the principal pattern
recognition receptors. They recognize conserved molecular
patterns of microbes, initiate rapid anti-microbial responses
protecting the host during the fist days of infection, and generate
danger-signals including cytokines and co-stimulatory molecules
required for activation of the adaptive immune system [1].
Regulation of the TLR signaling cascade is crucial for adequate
inflammatory responses and innate host defense, but also for
adaptive immune responses [2,3]. Additional signals for T helper
cell activation are provided by MHC class II molecules presenting
processed foreign peptides to antigen-specific T helper cells.
Patients suffering form septic shock express less MHC class II
molecules and show reduced LPS responsiveness indicating a role
of MHC class II molecules in innate immunity [4]. Here we
describe a function of MHC class II molecules in the innate host
defence. Expression of MHC class II molecules enhanced the
responsiveness of TLR to their ligands through co-localization in
lipid raft domains of the membrane.
Results
HLA-DR Increases the Responsiveness in Plasma
Membrane-Bound TLR Expressing HEK293 Cells
To assess a potential role of MHC class II molecules in the
innate immune response we compared expression of hBD-2 or
TNF in HEK293 cells transfected with HLA-DR and control cells.
The HEK293 cell line expresses neither HLA-DR molecules nor
TLR2, TLR4, or TLR7. We stably transfected these cells with the
respective TLR and/or HLA-DR. Quantitative real-time PCR
showed that TLR2 expression levels were 1.8 times higher in cells
expressing only TLR2 compared to cells expressing HLA-DR and
TLR2, while the HLA-DR/TLR4 or HLA-DR/TLR7 positive
cells expressed more TLR then the cells positive for only TLR4 or
TLR7 (3.5 times for TLR4 and 2.8 times for TLR7) (Figure S1A).
Since wild-type HEK293 cell lines and HEK293 cell line
expressing HLA-DR were of different origin, we compared the
gene expression of relevant molecules of the TLR signaling
cascade (Figure S1B). We did not detect significant differences in
the gene expression of these molecules.
To investigate the responsiveness of the HEK293 cell variants,
we stimulated the cells with TLR2 ligand BLP, TLR4 ligand LPS,
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or TLR7 ligand Loxoribine and assessed the expression of the
hBD-2 gene (TLR2 and TLR4) and of the TNF gene (TLR7) by
quantitative real-time PCR (Figure 1). In agreement with previous
reports [5,6], expression of TLR2 or TLR4 alone led to an
increase in hBD-2 production (3.7 times for TLR2, 31 times for
TLR4) and expression of TLR7 increased TNF production (5.9
times) after stimulation. Expression of HLA-DR alone was not
sufficient to confer responsiveness to BLP, LPS, or Loxoribine.
Co-expression of HLA-DR and TLR2 or TLR4 markedly
enhanced production of the antimicrobial peptide compared to
cells positive for TLR2 and TLR4 only (14.4 times for TLR2 and
75.1 times for TLR4, respectively). Co-expression of HLA-DR
and TLR7 failed to increase the TNF response compared to
TLR7 positive cells. Further, co-expression of HLA-DR lacking
the intracellular part failed to enhance the BLP-induced hBD-2
gene expression of HEK293 cells positive for TLR2 compared to
cells positive for only TLR2 (Figure 1D).
Peritoneal Macrophages of MHC Class II Knock-Out Mice
Show Impaired Responsiveness
We evaluated the contribution of MHC class II molecules to the
innate immune response in another experimental model. We
compared the cytokine response of peritoneal macrophages
isolated from wild-type and MHC class II knock-out mice [7] of
the same genetic background (C57BL/6) following treatment with
BLP or LPS. We found reduced TNF-a, IL-6, IL-10, IL-12, and
RANTES secretion in peritoneal macrophages of MHC class II
knock-out mice compared to those of the wild-type mice (Figure 2).
The gene expression of TLR2, TLR4, CD14, and of some
relevant molecules of the TLR signaling cascade were comparable
in wild-type and MHC class II knock-out mice (Figure S2).
TLR2 and HLA-DR Are Able to Interact Physically
We then assessed whether the functional synergism between
TLR and MHC class II molecules might be paralleled by their
physical interaction. Because the enhanced responsiveness in
TLR2 expressing cells was more significant than in TLR4
expressing cells, we carried out co-precipitation experiments with
the HEK293 cell line expressing TLR2 and HLA-DR. We found
that recombinant radioactively labeled TLR2 can be co-
precipitated with HLA-DR (Figure 3A). Furthermore, proximity
ligation assay (PLA) [8] showed that TLR2 was located closely
together with HLA-DR on HEK293 cells, whereas we did not
detect a co-localization of TLR2 and HLA-ABC (Figure 3B).
TLR2 and HLA-DR Collaborate in Aggregated Plasma
Membrane Rafts
We were not able to inhibit the enhanced responsiveness of
HLA-DR+/TLR2+ HEK293 cells with antibodies directed against
HLA-DR (data not shown). Moreover, the responsiveness of
intracellular located TLR7 was not enhanced by HLA-DR co-
expression. So, we wondered whether MHC class II molecules and
TLR2 collaborate in lipid raft domains of the cell membrane.
These membrane domains are rich in cholesterol and essential for
Figure 1. Expression of HLA-DR enhances TLR2 and TLR4 dependent activation of HEK293 cells. (A, B) Co-expression of HLA-DR in TLR2+
or TLR4+ HEK293 cells leads to enhanced hBD-2 expression (n$3) after stimulation with BLP and LPS, respectively (black bars) compared to untreated
cells (grey bars). (C) Co-expression of HLA-DR in TLR7+ cells did not increase the TNF expression (n = 3) after treatment with Loxoribine (black bars)
compared to untreated cells (grey bars). (D) Co-expression of HLA-DR lacking the intracellular part in TLR2+ HEK293 cells failed to enhance hBD-2
expression after stimulation with BLP (n = 3). Error bars represent standard errors; * p,0.05, ** p = 0.055.
doi:10.1371/journal.pone.0008808.g001
MHC Class II/TLR
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8808
efficient signaling processes [9,10,11,12]. A role of lipid rafts in
TLR-signaling has previously been reported [13]. We found that
Methyl-b-cyclodextrin (MCD) mediated destruction of lipid raft
domains inhibited BLP-triggered expression of the hBD-2 gene in
HLA-DR+/TLR2+ cells (Figure 3C). Adding of MCD saturated
with cholesterol acting as cholesterol donor [14] restored the BLP-
mediated responsiveness of HLA-DR+/TLR2+ cells (Figure 3C).
Moreover, immunofluorescence microscopy revealed that HLA-
DR and TLR2 co-localize in aggregated plasma membrane rafts
(Figure 3D).
Discussion
Our results reveal a novel and unexpected function of MHC
class II molecules. We show here that MHC class II molecules can
play a key role in innate immunity by enhancing TLR-mediated
cellular activation and antimicrobial effector mechanisms. We
suggest an underlying mechanism enhancing TLR-signaling
through co-localization with MHC class II in aggregated plasma
membrane rafts rather than direct binding of the ligand to MHC
class II. This is in agreement with the finding that MHC class II
failed to enhance the responsiveness of intracellularly located
TLR7. The observed effect is dependent on the intracellular part
of MHC class II although this part is not crucial for the
localization of MHC class II in aggregated plasma membrane
rafts [15].
The induction of MHC class II molecule expression by TLR
agonists [16,17], thus, not only enables effective antigen
presentation for the activation of adaptive immunity, but also
functions as a positive feedback mechanism enhancing TLR-
mediated responses. The innate immune response is a tightly
regulated process involving numerous stimulatory and inhibitory
molecules [18]. Over-reaction of the innate immune system may
lead to chronic inflammation, allergy, and autoimmunity.
Insufficient activation results in both inadequate protection during
the first days of infection and in inefficient or inappropriate
activation of the adaptive immune system, potentially leading to
disease or death. We have identified MHC class II molecules as
novel participants in the mechanisms controlling innate immune
responses.
Materials and Methods
Cell Lines and Media
The HEK 293 cell line was obtained from the American Type
Collection Culture. HEK293 cells transfected with HLA-DR (a-,
b-, and invariant chain) were a gift from Dr. J. Neefjes
(Netherlands Cancer Institute). These cells were stably transfected
Figure 2. Peritoneal macrophages from MHC class II knock-out mice show impaired responsiveness to BLP and LPS. (A–E) Cytokine
secretion of peritoneal macrophages from MHC class II knock-out mice (grey bars; n$4) is reduced compared to wild-type control mice (black bars;
n$3) after ex vivo stimulation with BLP and LPS. Error bars represent standard errors; ** p= 0.053, * p,0.05.
doi:10.1371/journal.pone.0008808.g002
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with an empty pCEP4 plasmid (Invitrogen), a pUNO-hTLR2/4/7
plasmid (InvivoGen), or with three plasmids coding for each chain
of HLA-DR lacking the intracellular tail using the TransIT-293
Transfection Reagents (Mirus). Cells were grown in DMEM
(Gibco BRL) supplemented with 10% low endotoxin FBS
(Hyclone) and 1% of an antibiotic-antimycotic solution (Gibco
BRL). Depending on the resistance genes present, medium was
supplemented with additional selection antibiotics G418, Hygro-
mycin (Roche Diagnostics), Ouabain (Sigma), or Blasticidin
(InvivoGen).
Cell Stimulation, Modulation of Cellular Cholesterol, and
Total RNA Extraction
HEK293 cells were grown in 6-well plates at 37uC in 5%
CO2 until they were 80% confluent and then stimulated for 6 h
with BLP (1 mg/ml, Pam3Cys-SKKKK, EMC microcollec-
tions), LPS (1 mg/ml, List Biological Laboratories) or Loxoribine
(1 mM, InvivoGen). For modulation of cellular cholesterol, the
cells were treated before stimulation with BLP for 1 h with
MCD (10 mM, Sigma-Aldrich), a 1:1 mixture of free MCD and
MCD saturated with cholesterol (Sigma-Aldrich), or MCD
Figure 3. TLR2 and HLA-DR interact physically in lipid raft domains. (A) Co-precipitation of labeled recombinant TLR2 (lane 1, 3, 4) or a
control protein (lane 2, luciferase) with HLA-DR molecules purified by immunoprecipitation with anti HLA-DR antibodies (lane 1, 2, 4) or control
antibodies (lane 3) from cell lysates of HLA-DR positive (lane 1, 2, 3) or negative (lane 4) HEK293 cells. A 14C-labeled molecular weight marker (in kD) is
shown in the left lane. (B) Proximity ligation assays showed that TLR2 and HLA-DR are close together (red signal), while TLR2 and HLA-ABC do not co-
localize (no red signal). Nuclei are stained by Hoechst 33342 (blue). (C) Treatment of TLR2+ (grey bars; n = 3) or HLA-DR+/TLR2+ (black bars; n = 3)
HEK293 cells with MCD, a lipid raft-destroying agent, prior to stimulation with BLP leads to impaired hBD-2 gene expression. The effect is restored via
adding MCD saturated with cholesterol acting as cholesterol donor. Error bars represent standard errors. (D) Immunofluorescence microscopy
showed that TLR2 (aTLR2-FITC; green) and HLA-DR (aHLA-DR-APC-Cy9; blue) co-localize in lipid raft domains (CT-rhodamine; red) of HLA-DR+/TLR2+
HEK293 cells (indicated by the white arrows). Pictures are representatives of at least five experiments.
doi:10.1371/journal.pone.0008808.g003
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saturated with cholesterol alone. MCD saturated with choles-
terol was prepared as described elsewhere [14]. In brief, 5 mM
MCD solution in DMEM medium was added to dry cholesterol.
The mixture was vortexed, sonicated, and shaken overnight at
37uC. The QIAmp RNA Blood Mini Kit (Qiagen) supplement-
ed with RNase-free DNase (Qiagen) was used for total RNA
isolation.
Ex Vivo Mouse Experiments
All mice were kept either at the Animal Facilities of the
University of Geneva Medical School or at the Section of Clinical
Immunology, University Hospital Zurich under optimised hygien-
ic conditions. All experiments were conducted in accordance with
the ethical guidelines of the Animal Studies Ethics Committee.
Peritoneal macrophages were isolated from wild-type (Harlan) and
MHC class II deficient [7] C57BL/6 mice. The macrophages
were cultured in X-VIVO 15 (BioWhittaker) over night and
stimulated (BLP 10 mg/ml; LPS 10 ng/ml) for 4 h in DMEM
supplemented with 10% low endotoxin FBS and 1% of an
antibiotic-antimycotic solution. Supernatants were analyzed with
the Bio-Plex HTF-System (Bio-Rad) using a kit of Bio-Rad.
Quantitative Real-Time PCR
Reverse transcription and quantitative real-time PCR were
performed with reagents from Applied Biosystems according to
the manufacturer’s instructions. Quantitative real-time PCR was
performed with an ABI Prism 7700 Sequence Detection
SystemTM (Applied Biosystems). For hBD-2 mRNA, primer
sequences were 59-GAGGAGGCCAAGAAGCTGC-39 (300 nM)
and 59-CGCACGTCTCTGATGAGGG-39 (300 nM), and the
probe had the sequence 59-TGGCTGATGCGGATTCAG-
AAAGGG-39 (250 nM). For 18S rRNA primer sequences were
59-AGTCCCTGCCCTTTGTACACA-39 (200 nM) and 59-G-
ATCCGAGGGCCTCACTAAAC-39 (200 nM), and the probe
had the sequence 59-CGCCCGTCGCTACTACCGATTGG-39
(250 nM). All oligonucleotides were synthesized by Microsynth.
All other primers and probe sets were purchased as pre-developed
assays by Applied Biosystems. Results were normalized relative to
18S rRNA using the comparative (DDCt) method according to the
manufacturer’s instructions (Applied Biosystems).
Co-Immunoprecipitations
Immunoprecipitations were performed using the ‘Cellular
Labeling and Immuoprecipitation Kit’ according to the manufac-
turer’s instructions (Roche Diagnostics). HEK293 cells were
collected in lysis buffer, sonificated, and insoluble material was
removed by centrifugation. To eliminate non-specific binding,
supernatants were incubated with 50 ml protein A agarose and
cleared by centrifugation. Immunoprecipitation was then per-
formed by mixing 1 mg of unlabeled anti-HLA-DR antibodies with
40 ml of the pre-cleared supernatant and 50 ml protein A-agarose.
The immunoprecipitates were collected by centrifugation, washed
and dissolved in 50 mM TBS (pH 7.5). Recombinant radio-
labeled proteins were synthesized using the TNT T7 Quick
Coupled Transcription/Translation System (Promega) and pBlue-
script KS (2) plasmids expressing TLR2 or luciferase. The
recombinant molecules were added to the immunoprecipitated
samples and complexes were collected by centrifugation, washed,
and analyzed by SDS-PAGE.
Proximity Ligation Assay (PLA)
Proximity ligation assays [8] were performed with the Duolink
in situ PLA kit of Olink Bioscience using a slightly different
protocol. Paraformaldehyde fixed HEK293 cells expressing HLA-
DR, TLR2, or both molecules were incubated with primary
antibodies made either in mouse or goat directed against HLA-DR
(BD Bioscience), TLR2 (R&D Systems), HLA-ABC (BD Pharmin-
gen), or an isotype control. Secondary anti-mouse and anti-goat
antibodies, conjugated to PLA oligonucleotides probe, were used
to detect primary antibodies. If these probes are located close
enough together, they hybridize and are ligated. Ligated probes
were amplified by a rolling-circle PCR, detected with fluorescently
labeled probes, and visualized with fluorescence microscopy.
Between all steps, cells were washed with PBS.
Immunofluorescence Microscopy
HEK293 cells expressing HLA-DR and TLR2 were grown
overnight on coverslips and fixed for 15 min. with 3% parafor-
maldehyde. Cells were stained by sequential 45 min. incubations
with rhodamin-labeled cholera-toxin-b-subunit (0.5 mg/ml; List
Biological Laboratories) to visualize the lipid raft domains [9], a
FITC anti-human TLR2 monoclonal antibody (T2.1;
eBioscience), and an APC-Cy9 anti-human HLA-DR monoclonal
antibody (L243; BD Biosciences). Cells were washed three times
with PBS between each staining step. Cells were mounted in
Glycergel (DakoCytomation) and observed with a Leica TCS SL
confocal microscope using the 63x/1.2 W CORR PL APO
objective (Leica).
Statistics
Statistical analyses of the results obtained in various groups were
performed with Mann-Whitney U test. A p-value of ,0.05 was
considered to be statistically significant.
Supporting Information
Figure S1 Gene expression of TLR and molecules of the TLR
signaling cascade in HEK293 cells. (A) TLR gene expression of
HEK293 cells only transfected with TLR (grey bars; n = 3) and
HEK293 cells transfected with TLR and HLA-DR (black bars;
n = 3). (B) Wild-type HEK293 cell lines obtained from the
American Type Collection Culture (grey bars; n = 5) expressed
comparable levels of molecules of the TLR signaling cascade genes
as HLA-DR+ HEK293 cell lines (black bars; n = 5) obtained from
Dr. J. Neefjes (Netherlands Cancer Institute). Error bars represent
standard errors.
Found at: doi:10.1371/journal.pone.0008808.s001 (1.05 MB TIF)
Figure S2 Gene expression of TLR, CD14, and molecules of the
TLR signaling cascade in peritoneal macrophages of wild-type and
MHC class II knock-out mice. Peritoneal macrophages of wild-
type mice (black bars, n = 4) express comparable amounts of
CD14, TLR2, TLR4, and molecules of the TLR signaling cascade
genes as peritoneal macrophages of MHC class II knock-out mice
(grey bars, n = 6). Error bars represent standard errors.
Found at: doi:10.1371/journal.pone.0008808.s002 (0.33 MB TIF)
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